Discover how a groundbreaking gene-editing technology is revolutionizing cholesterol management, potentially eliminating the need for daily medication. This breakthrough, while still in early stages, emphasizes the importance of healthy habits for heart health.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.
In a groundbreaking move, President Trump has negotiated significant price reductions for popular weight loss medications, bringing costs down to as low as $50 per month for eligible patients. Find out how these changes will affect access to essential treatments!
A new study reveals that many common prescription medications can disrupt the gut microbiome, leading to long-lasting health issues. Discover which drugs are affecting your gut health!
A staggering recall of over half a million blood pressure medication bottles has been announced due to unsafe levels of cancer-causing chemicals. Are you affected? Find out more!
A recent Gallup survey reveals a rapid increase in the use of injectable obesity treatments, correlating with a drop in obesity rates among U.S. adults. Discover the implications and future of these groundbreaking medications!
The heartbreaking story of 10-year-old Autumn Bushman, who faced bullying and tragic consequences linked to nighttime screen use. A mother's plea for change in how we protect our children.
A groundbreaking U.K. study examines over 150 clinical trials to reveal the physical side effects of antidepressants, offering a 'league table' of medications for informed choices. Learn how these findings can impact your treatment decisions!
For the first time, a study ranks the physical health side effects of antidepressants, revealing significant differences that could impact millions of patients in the UK. Discover how these findings could change treatment approaches.
In a major move against high prescription costs, AstraZeneca has agreed to sell its drugs at a discount through Medicaid, marking a significant win for the Trump administration's healthcare initiative.
